Abstract:This study reports the expression, purification, and renaturation of biologically active Transforming Growth Factor-beta(1) (TGF-beta(1)) fusion proteins from Escherichia coli (E. coli). A prokaryotic expression vector was engineered to produce tripartite fusion proteins consisting of (i) a purification tag, (ii) a protease-sensitive linker/collagen binding domain, and (iii) a cDNA sequence encoding the active fragment of human TGF-beta(1). The expressed fusion proteins TGF-B1-F1 and TGF-B1-F2, located in inclusion bodies, were solubilized with 8 M urea and renatured using a glutathione redox-coupled system and protracted dialysis under several experimental conditions. The purification of the recombinant proteins was achieved by binding the His-tag of the fusion proteins on a Ni-NTA metal chelate column The biological activity of the recombinant growth factor was demonstrated by its ability to inhibit mink lung (Mv1Lu) cell proliferation and/or to stimulate proliferation of NIH-3T3 mouse fibroblasts, where purified human platelet TGF-beta(1) served as a positive control. Purified TGF-B1-F1 and TGF-B1-F2 (collagen binding) constructs exhibited anti-proliferative activities comparable to purified platelet TGF-beta(1), but at lower specific activities. Binding of the renatured TGF-B1-F2 fusion protein to collagen was demonstrated by stable binding on a collagen-conjugated Sephadex-G15 column. The high affinity binding was also demonstrated by the binding of H-3-collagen to the TGF-B1-F2 protein immobilized on a Ni-NTA column. The TGF-B1-F2 fusion protein bound to collagen coated surfaces with high affinity but exhibited comparatively lower biological activity than the fusion protein in solution, suggesting a potentially latent configuration. Taken together, these results demonstrate that biologically active TGF-beta(1) fusion proteins can be recovered from transformed bacteria by oxidative refolding; thus, providing a means for its high-yield production, purification, and renaturation from microorganisms. Furthermore, these results support the concept that auxiliary domains may be used to modulate and/or target TGF-beta(1) for specific applications.

Expression, purification, and bioactivity of human tumstatin from Escherichia coli.

Cloning and expression of human tumstatin gene in E. Coli

Cloning and Expression of Human Tumstatin in Escherichia coli and Preparation of Its Polyclonal Antiserum

Human Tumstatin and Human Endostatin Exhibit Distinct Antiangiogenic Activities Mediated by Αvβ3 and Α5β1 Integrins

Physiological levels of tumstatin, a fragment of collagen IV α3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via αVβ3 integrin

Tumstatin45-132-TNFalpha suppresses tumour growth through anti-angiogenic effects and cytotoxicity.

Tumstatin Transfected into Human Glioma Cell Line U251 Represses Tumor Growth by Inhibiting Angiogenesis

Expression of Tumstatin183-230-TRAIL Fusion Protein and Identification of Its Biological Functions

19-Peptide, A Fragment of Tumstatin, Inhibits the Growth of Poorly Differentiated Gastric Carcinoma Cells in Vitro and in Vivo

Bifidobacteria Expressing Tumstatin Protein for Antitumor Therapy in Tumor-Bearing Mice.

Facile Purification of Escherichia Coli Expressed Tag-Free Recombinant Human Tumor Necrosis Factor Alpha from Supernatant

Expression, Purification and Characterization of A Novel Soluble Human Thymosin Alpha1 Concatemer Exhibited A Stronger Stimulation on Mice Lymphocytes Proliferation and Higher Anti-tumor Activity

Construction, expression, and purification of HIV-TAT-survivin (T34A) mutant: a pro-apoptosis protein in Escherichia coli.

Escherichia coli Nissle 1917 engineered to express Tum-5 can restrain murine melanoma growth.

Prokaryotic expression,purification and characterization of tissue inhibitor of metalloproteinase-2

Bacteria-mediated Tumor-Targeted Delivery of Tumstatin (54-132) Significantly Suppresses Tumor Growth in Mouse Model by Inhibiting Angiogenesis and Promoting Apoptosis

Inhibition effect of pcDNA-tum-5 on the growth of S180 tumor

Engineering, Expression And Renaturation Of Targeted Tgf-Beta Fusion Proteins

Expression, purification and characterization of human inhibitory receptor TIGIT in E.coli

Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2

Expression of soluble, biologically active recombinant human endostatin in Escherichia coli